Invex Therapeutics Ltd (ASX:IXC)
Australia · Delayed Price · Currency is AUD 0.1000
0.00 (0.00%)
Oct 27, 2026, 1:20 PM AEDT
Invex Therapeutics Market Cap
Invex Therapeutics has a market cap or net worth of 7.52 million as of October 29, 2026. It is the 44,604th most valuable company in the world and the 1,409th biggest in Australia. Its market cap has decreased by 23.08% in one year.
Market Cap
7.52M
Enterprise Value
3.50M
Revenue
46.83K
Global Rank
Country Rank
#1,409 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 5, 2019, Invex Therapeutics's market cap has decreased from 59.13M to 7.52M, a decrease of -87.29%. That is a compound annual growth rate of -24.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 7.52M | -16.67% |
| Dec 30, 2025 | 9.02M | 81.82% |
| Dec 23, 2024 | 4.96M | -18.52% |
| Dec 27, 2023 | 6.09M | -85.14% |
| Dec 28, 2022 | 40.96M | -22.70% |
| Dec 31, 2021 | 52.98M | -1.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ceryvyn Therapeutics | 13.68M |
| Argenica Therapeutics | 13.49M |
| Immuron | 13.24M |
| Cambium Bio | 12.36M |
| AdAlta | 9.64M |
| Zelira Therapeutics | 5.95M |
| Acrux | 5.90M |
| Tissue Repair | 5.74M |